Close this search box.

Adium Group continues to consolidate its strategic growth in Latin America

Adium is strategically expanding its portfolio by developing its key therapeutic areas throughout Latin America. By means of this agreement, Adium will acquire a range of Takeda mature assets, thus expanding its gastrointestinal line product portfolio in several Latin American countries. Adium will be supplied by Takeda developed products, granting patients with continuous access over […]

We use cookies on our website to provide you the most relevant experience by remembering your preferences and repeat visits. By Clicking "Accept", you agree to the use of all cookies.